Asian Scientist MagazineModified CRISPR Gene Editing Proves Highly AccurateAsian Scientist MagazineThe main protagonist of the current third-generation DNA scissors is CRISPR, a tool that is quicker and cheaper than its predecessors. By cutting out a s… Continue reading
Allied Physical Medicine in Dallas Joins R3 Stem Cell, Now Offering Regenerative Stem Cell ProceduresBenzingaAllied Physical Medicine in Allen, Texas has joined R3 Stem Cell and is now offering regenerative stem cell procedures. The therapies are succe… Continue reading
|
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
PR Newswire (press release) “Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022” report gives comprehensive insight on clinical and non-clinical developments in the field … |
|
Drs. Oz and Roizen: Put diabetes in remission; beware of stem–cell treatments for AMD
News Sentinel Q: I hear there’s a clinic in Canada that can medically cure Type 2 diabetes without bariatric surgery. I was diagnosed two years ago. Is this true? — William T., Bozeman, Mont. A: It’s almost true. Because Type 2 is a chronic disease, when you have … |
MIT Technology Review |
Immunotherapy Pioneer James Allison Has Unfinished Business …
MIT Technology Review On the day I arrive at MD Anderson Cancer Center in Houston to meet James Allison and his longtime collaborator Padmanee Sharma, they are nowhere to be … CRISPR genome editing and immunotherapy – the early adopterMedical Xpress Cancer immunotherapy market forecast to 2021 available in new …WhaTech |
Pittsburgh Post-Gazette |
In Pittsburgh, oral immunotherapy treatment for allergies in its infancy
Pittsburgh Post-Gazette Six-year-old Eva of Mt. Lebanon is one of just a few children in Pittsburgh receiving oral immunotherapy (OIT) for a peanut allergy. Dissolved inside Eva’s fruit punch Kool-Aid was a minuscule amount of peanut powder. Two months ago, it would have … |
Genetic Engineering & Biotechnology News (press release) |
Streamlining Stem Cell Manufacturing
Genetic Engineering & Biotechnology News (press release) Stem cell therapies hold extraordinary potential to revolutionize human medicine. Indeed, the global market for cell-based therapies is expected to surpass $20 billion by 2025, with an annual growth rate of 21%, as estimated by Scientia Advisors … |
|
Treating Cerebral Palsy With UCB Stem Cells
Financial Tribune The biggest national project to treat patients with cerebral palsy (CP) through injection of stems cells from umbilical cord blood (UCB) into the brain began its trial run in March. The project is jointly undertaken by Royan Institute, Children’s … |